BE707409A - - Google Patents
Info
- Publication number
- BE707409A BE707409A BE707409DA BE707409A BE 707409 A BE707409 A BE 707409A BE 707409D A BE707409D A BE 707409DA BE 707409 A BE707409 A BE 707409A
- Authority
- BE
- Belgium
- Prior art keywords
- ursolic acid
- acid
- analgesic
- inflammatory
- excipient
- Prior art date
Links
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 claims description 17
- 229940096998 ursolic acid Drugs 0.000 claims description 17
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 5
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 4
- 230000000202 analgesic effect Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000000454 talc Substances 0.000 claims description 3
- 229910052623 talc Inorganic materials 0.000 claims description 3
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 2
- 108010010803 Gelatin Proteins 0.000 claims description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 229940110456 cocoa butter Drugs 0.000 claims description 2
- 235000019868 cocoa butter Nutrition 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 2
- 229940093471 ethyl oleate Drugs 0.000 claims description 2
- 239000003925 fat Substances 0.000 claims description 2
- 235000019197 fats Nutrition 0.000 claims description 2
- 239000008273 gelatin Substances 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011852 gelatine desserts Nutrition 0.000 claims description 2
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000000395 magnesium oxide Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 235000012222 talc Nutrition 0.000 claims description 2
- -1 ampoules Substances 0.000 claims 1
- 150000002334 glycols Chemical class 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 238000001914 filtration Methods 0.000 description 7
- 150000003505 terpenes Chemical class 0.000 description 7
- 235000007586 terpenes Nutrition 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 241000549168 Maytenus Species 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- RLQZIECDMISZHS-UHFFFAOYSA-N 2-phenylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C=CC(=O)C(C=2C=CC=CC=2)=C1 RLQZIECDMISZHS-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940068917 polyethylene glycols Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE707409 | 1967-12-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE707409A true BE707409A (enrdf_load_stackoverflow) | 1968-04-16 |
Family
ID=3851908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE707409D BE707409A (enrdf_load_stackoverflow) | 1967-12-01 | 1967-12-01 |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE707409A (enrdf_load_stackoverflow) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0774255A1 (en) * | 1995-11-16 | 1997-05-21 | JCR PHARMACEUTICALS Co., LTD. | Use of ursolic acid for the manufacture of a medicament for suppressing metastasis |
| WO1998037899A1 (en) * | 1997-02-28 | 1998-09-03 | Dong Kook Pharmaceutical Co., Ltd. | Liver protection or treatment agents comprising asiatic acid derivatives as the active component |
| US20120135094A1 (en) * | 2009-05-14 | 2012-05-31 | Rutgers, The State University Of New Jersey | Oregano and mint anti-inflammatory compositions and methods |
-
1967
- 1967-12-01 BE BE707409D patent/BE707409A/fr unknown
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0774255A1 (en) * | 1995-11-16 | 1997-05-21 | JCR PHARMACEUTICALS Co., LTD. | Use of ursolic acid for the manufacture of a medicament for suppressing metastasis |
| CN1073843C (zh) * | 1995-11-16 | 2001-10-31 | 日本化学研究股份有限公司 | 熊果酸或其盐在制备抑制转移的药物中的应用 |
| WO1998037899A1 (en) * | 1997-02-28 | 1998-09-03 | Dong Kook Pharmaceutical Co., Ltd. | Liver protection or treatment agents comprising asiatic acid derivatives as the active component |
| US20120135094A1 (en) * | 2009-05-14 | 2012-05-31 | Rutgers, The State University Of New Jersey | Oregano and mint anti-inflammatory compositions and methods |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH639369A5 (fr) | Benzamides heterocycliques substitues et leurs procedes de preparation. | |
| CN115960156A (zh) | 一种利用酵母提取麦角甾醇的方法 | |
| BE707409A (enrdf_load_stackoverflow) | ||
| CA1181340A (fr) | Compositions pharmaceutiques renfermant des derives de l'acide 4-phenyl-4-oxo 2-butenoique | |
| US3553236A (en) | Psoralene and isopsoralene, process for their isolation and separation | |
| FR2472557A1 (fr) | Procede de resolution de l'acide d,1-2-(6-methoxy-2-naphtyl)-propionique et son application a un melange de sels des formes d et l de cet acide avec une n-alkyl-d-glucamine | |
| EP0012640A1 (fr) | Procédé de purification de l'acide chénodésoxycholique et produits obtenus par ce procédé | |
| US2863909A (en) | Process of extracting 1, 4-dicaffeyl-quinic acid | |
| CH646146A5 (fr) | Derive du 1alpha,25-dihydroxy cholecalciferol et son procede de preparation. | |
| RU2676304C1 (ru) | Способ получения лаппаконитин гидробромида | |
| US2577076A (en) | Purification of benzhydryl ethers | |
| JPH05112488A (ja) | １０−ヒドロキシ−δ−２−デセン酸の製法 | |
| Wisniak | Charles-Joseph Tanret: natural principles | |
| Dj et al. | Obtaining Gossypol Acetic Acid (Gsk) From Gossypol | |
| Islamov et al. | Getting of gossipol acic acid (GSK) | |
| CH294337A (fr) | Procédé de préparation d'un amino-propanediol optiquement actif. | |
| SU254701A1 (ru) | СПОСОБ ФРАКЦИОНИРОВАНИЯ СМЕСИ ЖИРНЫХ КИСЛОТ, ПОЛУЧЕННЫХ ИЗ ХЛОПКОВОГО СОАПСТаКА | |
| CZ280388B6 (cs) | Způsob čištění o-(2,6-dichloranilino)fenyloctanu sodného | |
| BE663020A (enrdf_load_stackoverflow) | ||
| CH297193A (fr) | Procédé de préparation de 5,7,9-prégnatriène-3(B)-ol-20-one. | |
| CH206038A (fr) | Procédé de préparation d'un dérivé du tétrahydronaphtoquinol. | |
| CH587288A5 (en) | Demesterol extraction - from apocynaceae esp. Funtumia Elastica | |
| CH363978A (fr) | Procédé pour la préparation de l'a-estradiol | |
| BE572572A (enrdf_load_stackoverflow) | ||
| CH304885A (fr) | Procédé de préparation d'un dérivé du 4-prégnène. |